A detailed history of Atom Investors LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atom Investors LP holds 5,551 shares of BMY stock, worth $230,533. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,551
Previous 23,921 76.79%
Holding current value
$230,533
Previous $1.23 Million 75.47%
% of portfolio
0.04%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $881,392 - $999,328
-18,370 Reduced 76.79%
5,551 $301,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $1.16 Million - $1.38 Million
23,921 New
23,921 $1.23 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $309,547 - $343,019
5,390 New
5,390 $325,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.